For many years, the isolated perfused rat liver (IPRL) model has been used to investigate the physiology and pathophysiology of the rat liver. This in vitro model provides the opportunity to assess cellular injury and liver function in an isolated setting. This review offers an update of recent developments regarding the IPRL set-up as well as the viability parameters that are used, with regards to liver preservation and ischaemia and reperfusion mechanisms.
For many years, the isolated perfused rat liver (IPRL) model has been used to investigate the physiology and pathophysiology of the rat liver. This in vitro model provides the opportunity to assess cellular injury and liver function in an isolated setting.
The IPRL model was first reported by Claude Bernard in 1855 (Gores et al. 1986 ).
In the review about the IPRL written by Gores et al. in 1986 , the authors stated that the model remained a valuable reperfusion model, although other methods such as the assessment of liver slices, cell cultures, cell suspensions and isolated organelles had emerged. To date, the IPRL provides valuable data in studies regarding liver physiology using new techniques in the field of molecular biology and genetics.
In the field of liver preservation, the IPRL model has been used for, among others, assessment of ischaemia-reperfusion injury, metabolism of perfusate compounds, metabolism of ammonium and amino acids (Haussinger 1987) , endothelial function using hyaluronic acid uptake (Reinders et al. 1996) , oxygen consumption (Dahn et al. (Tavill 1972 , Lindell et al. 1994 .
1999) and synthesis of proteins
Liver injury at reperfusion is, after immunological rejection, the second most important cause for graft non-function. Therefore, a reliable ischaemia-reperfusion model is valuable for the evaluation of liver preservation and transplantation methods. During liver preservation and subsequent transplantation, there are two crucial phases, i.e. the ischaemic phase and the reperfusion phase, both contributing to the eventual damage of the graft. During cold ischaemia, damage occurs due to adenosine triphosphate (ATP) depletion, cell membrane dysfunction and consequent cell swelling (Belzer & Southard 1988) , as well as damage to the cytoskeleton (Lemasters & Thurman 1995) , altered Ca þ þ homeostasis (Bellomo & Orrenius 1985 , Cotterill et al. 1989 ) and production of hypoxanthine. During reperfusion when the organ is warmed up and reoxygenated, oxygen-free radicals are produced and superoxides are formed by hypoxanthine. This all results in microvascular damage and perfusion failure, known as the no-reflow phenomenon (Vollmar et al. 1994 , Mazzoni et al. 1995 . These processes, among others, can be studied in an isolated rat liver reperfusion model.
The IPRL model allows simulation of in vivo conditions and standardization of experimental conditions. However, the conditions for IPRL research remain limited (Cheung et al. 1996) . Essential dissimilarities with in vivo reperfusion in a rat liver transplantation model are the lower partial oxygen pressure, the composition of the perfusion solution and the absence of interaction with blood, leucocytes and other organ systems (Sahin & Rowland 1998) . The main reason why the IPRL model is still widely used is the absence of alloreactions and the controlled setting in which experiments can be reliably reproduced. It furthermore allows a significant reduction in the use of laboratory resources and animals compared with the rat liver transplantation model. This reduction is seen for several reasons: firstly, two animals are needed for each transplantation experiment and only one for the reperfusion model. Secondly, the IPRL is more standardized and thereby has a higher power, resulting in the need for less animals per experimental group. Thirdly, liver transplantation in the rat is a complex procedure requiring a substantial learning curve before consistent results are obtained, whereas the IPRL is technically a simple procedure. However, lack of conformity between research groups has resulted in large variations in set-up and usage of the IPRL. Standardization of the IPRL model thus is an important tool to enhance comparison of published results and to improve future experimental designs.
The aim of this review is to update recent developments regarding the IPRL set-up as well as the parameters that are used to assess liver damage and function. Furthermore, a standardized set-up is presented for application of the IPRL model in the laboratory.
A review of the literature on various methods and applications of the IPRL was performed using the Medline (Pubmed) database. The used search term was 'isolated perfused rat liver'. A total of 3405 articles were retrieved, covering the period between 1965 and 2003. The search was narrowed to articles in English regarding liver preservation or liver ischaemia and reperfusion. Finally, 291 articles were considered relevant for this review. These articles were categorized into papers concerning experimental models and papers regarding viability assessment.
Animals
In the IPRL model, different strains of rats can be used. For liver ischaemia and reperfusion studies, Wistar rats are most often used, as well as Sprague-Dawley, ACI, Lewis and Fisher rats. For specific purposes, such as a steatosis model, genetically modified rats (Zucker) or animals using a special diet (choline or choline-methionine deficient diet) are used (Astarcioglu et al. 2004 , Marsman et al. 2004 , Tovar et al. 2005 .
As far as the nutritional state of the rats is concerned, many studies have been Laboratory Animals (2006) 40 performed comparing fed and fasted rats for ischaemia and reperfusion studies. Fujita et al. (1993) described the effects of nutritional status on hypothermic liver perfusion and concluded that concerning release of liver enzymes, the fed rats had better results than fasted rats. Arnault et al. (2002) concluded that a long-fasting period is deleterious compared with feeding, but that this effect can be compensated by infusion of alanine at reperfusion. Imamura et al. (1995) showed that the nutritional status of liver donors does not play an important role in the preservation of liver endothelial cells after cold ischaemia-reperfusion and, thus, should not affect the overall resistance of livers to hypothermic-ischaemic injury. From these and other studies, no conclusions can be drawn regarding the optimal nutritional state of the donor before liver preservation and reperfusion.
Regarding the age of rat liver donors, several studies have been performed to compare certain liver functions in young and old rats. Mollica et al. (2001) described the enhanced mitochondrial respiration and biosynthetic function of young (90 days) versus old (22-24 months) rats. Handler and Brian (1997) stated that rates of mixedfunction oxidation are decreased in intact livers from senescent (22-24 months) compared with young adult rats (3-6 months), possibly due to age-related changes in co-factor supplies.
The use of either male or female rats is dependent on the study design. Usually, in ischaemia and reperfusion studies, the male rat is chosen because of the absence of monthly hormonal differences, thereby obviating a potential bias in standardization of the experiment. However, hardly any studies have been performed to compare male and female rat livers in ischaemia and reperfusion research. A study by Orzes et al. (1985) described that low doses of sulphobromophthalein are taken up by the liver more efficiently in female than in male rats as is consistent with a sex-related difference in the affinity but not in the number of the sulphobromophthalein highaffinity uptake sites.
IPRL set-up
Features of the IPRL that are part of a standardized set-up are as follows: perfusate type and volume; perfusion pressure and flow; perfusion temperature; perfusion duration; oxygenation.
Perfusate type and volume Gores et al. (1986) stated that the reperfusion medium in the IPRL ideally needs an appropriate buffer, energy source, colloid osmotic pressure capacity and an oxygencarrying capability. The most widely used reperfusion solution is Krebs-Henseleit buffer (KHB) (Krebs & Henseleit 1932) , containing 10 mM glucose as an energy substrate, bicarbonate-carbon dioxide as a buffering agent and bovine serum albumin (BSA) as an oncotic agent. BSA was not included in the original KHB solution. Although it has been shown that BSA in KHB may be toxic for hepatocytes (Mischinger et al. 1992 ) and causes excessive foam formation during reperfusion, its use is still maintained. Other reperfusion solutions used are 3-(N-morpholino)propane sulphonic acid (MOPS)-buffered Ringers solution (Cheung et al. 1996) , rat blood diluted in KHB (Alexander et al. 1995) , modified physiological saline (Ahmed et al. 2001) and culture media such as minimal essential medium (MEM). Comparative studies regarding these reperfusion solutions are absent and therefore the choice for one or the other reperfusion solution is based on the experience of the investigator and on the used viability assays. Assessment of protein synthesis can require an amino acid containing solution, such as L-15 or MEM (Lindell et al. 1994) .
The volume of perfusate in the literature ranges from 150 to 500 mL and depends on the design of the reperfusion circuit (Alexander et al. 1995 , Compagnon et al. 2001 . Unfortunately, perfusate volumes are not mentioned in many articles, although the volume of the perfusate is an essential factor in determining the concentration of perfusate elements. Furthermore, a large perfusate volume could lead to concentrations that might not reach the detection limit of certain assays.
Perfusion pressure and flow
In the normothermic recirculating IPRL model with perfusion via the portal vein, the applied portal pressure lies between 8 and 10 mmHg and thus remains within physiological limits, i.e. 8-12 mmHg (Gores et al. 1986) . A higher perfusion pressure potentially causes barotrauma of the liver and injury to the sinusoidal endothelial cells, resulting in leakage of large particles into the space of Disse due to an enlargement of the sinusoidal fenestrations. A lower perfusion pressure will result in inhomogenous distribution of the perfusate, leaving large areas of the liver non-perfused. An increasing perfusion pressure during reperfusion reflects deterioration of the microcirculatory system of the liver and can be used as a read-out parameter of microvascular integrity (see below).
The physiological blood flow in the rat portal vein at 371C is 1.25 mL/min/g liver weight (Ginsberg & Grayson 1952 , Gores et al. 1986 ). Higher flow rates are used in IPRLs using perfusion solutions without blood cells. By increasing the flow rate of perfusion solutions, which do not contain an additional oxygen carrier, sufficient oxygen can still be supplied to the liver parenchyma. However, the increased flow rate should not exceed 5 mL/min/g liver weight in order to prevent injury to the sinusoidal endothelial cell lining (Gores et al. 1986) . Optimal perfusion flow is 3 mL/min/g liver weight, resulting in an acceptable portal perfusion pressure (Sherill & Dietschy 1972) .
The IPRL system can be flow-controlled or pressure-controlled. The main difference between these two perfusion systems is the response of the liver microvasculature. In the pressure-controlled system, the flow will decrease as a result of increased intravascular resistance, thus preventing endothelial cell damage. An important drawback of this set-up is the risk of incomplete liver perfusion. In the flowcontrolled system, the pressure in the liver can rise and the resulting increased intravascular resistance will ultimately lead to injury to the endothelial cells. Extensive liver injury is recognized not only by an increase in damage parameters but also by a rapid increase in vascular resistance. In our view, pressure-controlled systems are preferred because they simulate physiological homeostasis.
The IPRL model is mostly used with perfusion of the portal vein only, disregarding the hepatic artery and its branches to the peribiliary capillary plexus. Not only in investigations focusing on bile flow, bile transport and transporters of bile components but also in studies concerning hepatic flow experiments, a reperfusion model using the portal vein as well as the hepatic artery is favoured to optimize liver viability, the so-called isolated dual perfused rat liver (IdPL). Total perfusion flow of 3.0 mL/min/g liver weight is established by a portal flow of 2.4 mL/min/g liver weight and an arterial flow of 0.6 mL/min/g liver weight. The portal vein is perfused by a roller pump and the hepatic artery by a pulsatile pump at 360 bpm. Cannulation of the coeliac artery is the preferred technique for IdPL experiments (Sahin & Rowland 1998) . Yang et al. (2000) reported that the IdPL model allows an increase in reperfusion time. However, when taken into account that the flow distribution in the rat liver is 10% arterial and 90% portal (Shibayama & Nakata 1991) , the IdPL can be regarded as a special model for specific study aims (Gardemann et al. 1991) .
Perfusion temperature
Perfusion is usually performed at 371C, but the exact core liver temperature often varies. The importance of maintaining a constant temperature is not always recognized, leading to discrepancies in results. A deviation of even a single degree celsius in liver temperature can have a substantial effect on ischaemia-reperfusion injury (Heijnen et al. 2001 temperature-controlled conditions allowing more than 11 variation (Sahin & Rowland 1998) will lead to distorted results. Measurement of temperature is, in our opinion, preferred at the inflow site of the liver, precluding damage of the liver parenchyma by the probe, which might cause microvasculatory disturbances or oxygen leakage.
Perfusion duration
The perfusion period should suffice for equilibration between liver temperature and perfusion solution temperature in order to reliably allow functional assessment. After a certain period, the H þ -buffering capacity of the perfusate and the energy sources (glycogen) are exhausted, which results in rapid deterioration of the liver. Without correction, the perfusate will become acid due to anaerobic glycolysis and leakage of lytic enzymes and other cell contents as a result of hepatocellular necrosis. In transplantation-related studies, the liver should undergo a period of 10-30 min poikilothermic rewarming without perfusion followed by equilibration of liver and perfusate. After this equilibration period, the reperfusion phase of the experiment is started for the duration of 40-120 min (El Gibaly et al. 2004) .
Oxygenation
One of the major drawbacks of the IPRL system is the inadequate oxygenation of the liver parenchyma, which inevitably leads to anaerobic glycolysis and intracellular acidosis. Oxygenation can be enhanced by increasing the partial oxygen pressure of the perfusate through: (1) increasing the flow through the portal vein. Increasing perfusate flow results in a net increase of supply of oxygen molecules to the parenchyma but is limited to 3 mL/min/g liver weight to prevent shear-stress-induced injury to the sinusoidal lining cells; (2) oxygenation with 100% oxygen instead of carbogen (95% oxygen, 5% carbon dioxide). Carbon dioxide is however required in the buffer system of all perfusion solutions containing HCO 3 À ;
(3) addition of oxygen carriers such as perfluorcarbons or erythrocytes to the perfusate. The use of erythrocytes requires the use of more laboratory animals for one single experiment and furthermore induces the risk of alloreactions. When erythrocytes are added to the perfusion solution, inbred rats should be used to minimize alloreactivity to blood components of the donor rat; (4) by using an adequate oxygenator (for example, the hollow fibre oxygenator or the so-called Hammilton lung); (5) the use of smaller livers requires less oxygen saturation of the perfusate and can thus decrease anaerobic glycolysis. Oxygenation of a liver of a rat weighing 250-300 g will be sufficient if a pO 2 of more than 500 mmHg is provided to the liver, resulting in a posthepatic pO 2 of more than 100 mmHg (ambient air ¼ 159 mmHg).
Parameters used in the IPRL
In the following paragraphs, we will discuss the commonly used, validated parameters as well as experimental parameters in order to provide reliable viability and function markers to be used in IPRL studies.
Parameters for liver damage
Hepatocellular injury Hepatocytes constitute the largest cell mass of the liver, about 70% (Junqueira et al. 1992) . In the event of cell lysis, hepatocellular enzymes are released into the perfusate. Although aspartate aminotransferase (AST) is not a liver-specific enzyme, it is an accurate damage marker in the IPRL. AST is present in both cytoplasm and mitochondria of hepatocytes and release is increased more profoundly with severe liver damage (AST/ALT >1). Alanine aminotransferase (ALT) is mainly present in the cytoplasm of hepatocytes and its release already increases with minor liver damage (AST/ALTo1). Lactate dehydrogenase (LDH) is also not a liver-specific enzyme. LDH catalyses the interconversion of pyruvate and lactate. The enzyme LDH is present not only in hepatocytes but also in nonparenchymal cells. Therefore, it serves as a general tissue-damage marker.
Sinusoidal endothelial cell injury Endothelial cell viability is of importance in the preservation of donor livers since these cells are even more vulnerable to cold ischaemic injury than hepatocytes (Caldwell-Kenkel et al. 1989) .
Hyaluronic acid (HA) is a glycosaminoglycan produced in connective tissue and synovial membranes throughout the body. It enters the circulation from the lymphatic system and it is predominantly taken up and metabolized by the sinusoidal endothelial cells (Fraser et al. 1985 , Deaciuc et al. 1993 , Itasaka et al. 1995 . The spleen and bone marrow are responsible for part of the uptake and degradation, but not in the quantities they are found in the liver (Fraser et al. 1985 , Deaciuc et al. 1993 . Although HA has been suggested as a viability marker, some studies have shown that measurement of HA in the effluent of cold-stored human livers is unreliable (Karayalcin et al. 1993) . Poor sensitivity of HA measurement assays was suggested as well (Tabet et al. 1997) . We found that HA is a good and reproducible marker to determine endothelial viability.
Purine nucleoside phosphorylase (PNP) catalyses the reversible conversion of inosine to ribose-1-phosphate and hypoxanthine in the presence of inorganic phosphate (the catabolism of adenine nucleotides). This enzyme is localized in non-parenchymal cells like the vascular endothelium and Kupffer cells and is, therefore, proposed as a marker of oxidative injury to liver endothelial cells (Rashed & Patel 1987 , Rao et al. 1990 , Minor et al. 1995 . Others reported that PNP is not discriminative for endothelial cells and that it is released by parenchymal cells as well (Brass & Mody 1995) .
Parameters for liver function
Bile production is readily monitored during reperfusion via cannulation of the bile duct and collection of bile, and has long been considered as one of the most important parameters of liver function. The level of bile production is, however, strongly related to perfusate flow. Furthermore, the production of bile can be impeded by inadequate positioning of the bile cannula. A more recently used liver function parameter, clearance of indocyanine green into bile, can adequately reflect liver function as well (Burns et al. 1989) .
Parameters for energy metabolism
ATP is produced by oxidative phosphorylation and glycolysis. It is essential for maintenance of cellular structure and function. In the IPRL, the ATP content of the liver can only be measured after completion of the experiment, reflecting the ability of the liver to restore energy metabolism after preservation. Results can be presented as the energy charge potential (ECP) as described by Atkinson (1968) , ECP ¼ (ATP þ 1/2 ADP)/ (ATP þ ADP þ AMP) or by the thermodynamical description ATP/(ADP Â P i ) (Groen et al. 1982) . Tissue concentrations of energy-rich adenine nucleotides can be determined after freeze-clamping of liver tissue biopsies followed by standard enzymatic tests (Helzberg et al. 1987) . A confounding factor is the relation with tissue oxygenation. In case of insufficient oxygenation during reperfusion, with as a consequence anaerobic glycolysis, the enzyme AMP-dependent protein kinase is activated (Hardie 2003) . This enzyme causes ATP-requiring processes to slow down, with concomitant activation of ATP-producing processes. ATP content might, therefore, not provide a clear view of the energy status of the liver during reperfusion, unless AMPdependent protein kinase is determined (Reckendorfer et al. 1992 , Soboll et al. 1998 .
Histology
In the analyses of IPRL-related studies, only a few authors have mentioned histological evaluation of liver biopsies that are acellularly reperfused. No consensus has been reached for the histological classification of parenchymal damage, integrity of sinusoidal spaces, development of vacuoles, necrosis and apoptosis, and other typical microscopical features. A reliable classification of hepatic morphology is adapted from Tojimbara et al. et al. (2000) allowing for a scoring method that is based on hepatocyte integrity and intact intercellular connections. The proposed method offers a guideline for morphological classification of hepatic injury, graded on a scale of 1 (excellent) to 9 (poor): (1) normal rectangular structure of the hepatocytes; (2) rounded hepatocytes with an increase of sinusoidal spaces; (3) vacuolization in zone 3; (4) vacuolization in zone 2; (5) vacuolization in zone 1; (6) vacuolization and nuclear pyknosis in zone 3; (7) vacuolization and nuclear pyknosis in zone 2; (8) vacuolization and nuclear pyknosis in zone 1 and (9) necrosis (Figure 1) . The evaluation of liver tissue according to this method is also described by 't Hart et al. 
Discussion of additional parameters
Although the IPRL is a validated and standardized model, many disparities can be found in literature among research groups employing the IPRL. In this communication, we have summarized the validated parameters commonly used in the IPRL. However, older as well as more recent studies have shown other options for the assessment of liver damage and liver function. To assess hepatocellular injury, the concentration of liver enzymes in the perfusate is measured, but release of these liver enzymes in vivo occurs late (6-24 h) (St Peter et al. 2002a,b) . Depending on the type of experiment and the objectives of the study, a parameter for early hepatocyte damage can be required. Alpha glutathione S-transferase (a-GST) provides such a parameter (Trull et al. 1994 , Tiainen et al. 1996 . It is a cytosolic enzyme, predominantly localized in hepatocytes and has proven to be an early and sensitive parameter for hepatocellular membrane damage (Vaubourdolle et al. 1993 , Trull et al. 1994 , Tiainen et al. 1996 , van Wagensveld et al. 1997 . Due to its high cytosolic concentration, it is released into the perfusate before a rise in AST, ALT or LDH can be detected. Glutamate dehydrogenase (GLDH) is a liver-specific enzyme, localized in mitochondria. Release of GLDH into the perfusate has been shown to be a reliable marker of severe hepatocellular damage. Alternative methods to assess liver function have been introduced in the past decades. Well-established function tests are the ammonia clearance and urea synthesis assays. Both parameters provide us with information about metabolic activity of the liver (Kerly & Spruyt 1971 , Haussinger 1987 , Zange et al. 1993 , Pastor et al. 1998 . When ammonia is added to the perfusate, in the presence of CO 2 , HCO 3 , lactate and ornithine, the clearance of ammonia and the resulting production of urea can be measured. Urea is not entirely produced from ammonia and its conversion is dependent on acidity. The formation of urea itself is also responsible for extracellular acidification (Haussinger et al. 1986) .
Lidocaine clearance represents the activity of cytochrome P-450 (McKindley et al. 1999) and the production of albumin provides us with a marker of synthesis capacity. Another way to assess liver function is by analysing the composition of bile, bile consists predominantly of bile acids, lecithin, cholesterol, phospholipids and glutathione. Apart from the possibility to assess the composition of bile, it is feasible to add bile acids to the perfusate, allowing the clearance rate to be measured (St Peter et al. 2002a,b) . For reperfusion periods that do not exceed 90 min, intracellular supplies of bile acids are sufficient to allow production of bile during the experiments. Addition of taurocholic acid to the perfusion solution is only recommended for experiments that last longer. A parameter of liver function related to energy status is the lactate/pyruvate ratio: the measurement of lactate production alone to quantify the amount of anaerobic glycolysis is useless without the measurement of pyruvate. The ratio between these two values has to be o10. This ratio provides us with information about the respiratory cycle.
The assessment of cytokines, as produced by neutrophils and macrophages (Kupffer cells), can provide us with information on the inflammatory response in the reperfused liver. However, the measurement of cytokines is hardly ever used in IPRL studies (Itasaka et al. 1995 , Gao et al. 1997 . This is probably due to the fact that the concentration of cytokines such as tumour necrosis factor (TNF)-alpha and interleukin (IL)-10 in the perfusate is below the detection limit. When measured in liver homogenates, cytokines can be detected. However, reperfusion is performed with an acellular solution and therefore, no clinically relevant data are obtained.
The measurement of oxidative stress is of great importance in liver ischaemia and reperfusion studies, since oxygen-free radicals are produced during the reperfusion phase. Oxidative stress can be measured by malondialdehyde (MDA), glutathione (GSH) and superoxide dismutase activity (SOD) (Kanko et al. 2005) .
Having reviewed the literature of the past 25 years and having discussed the methods used in our laboratories, we came up with the following recommendations for the use of the IPRL model for experimental liver ischaemia/reperfusion studies ( 
